P&G is looking for new technology-enabled solutions, services and business models that incentivize and drive lasting behavior change.
Startup Lightning Talks - 2022 MIT Health Science Technologies Conference The Future of Cell & Gene Therapies
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Scalable production of RNA for agriculture Andrey Zarur, Cofounder & CEO, GreenLight Biosciences Potassium fertilizer innovation Philip Wender, Managing Director, Advanced Potash Technologies Chemiresistive gas sensing for food safety Merry Smith, Senior Scientist, C2Sense Novel dehumidifying material for indoor farms Sorin Grama, Cofounder, Transaera Probiotics for plants Michael Miille, CEO, Joyn Bio [Joyn is a JV between Ginkgo Bioworks and Leaps by Bayer]
Startup Lightning Talks presented at the 2024 MIT Tokyo Life Science Symposium.
Anglo American, a British mining company, is looking for startups in bio technology, rapid access, improved recovery, dry processing, mining legacy, sensor fusion, and EPC disruption.
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
JC Gutiérrez-Ramos, President and CEO, Synlogic